Introducing RapidCert™ Biological Indicator (BI) Sterility TestingNelson Labs’ patent-pending solution for quicker sterility confirmation. Learn More
Header Artwork
Header Artwork

ON-DEMAND WEBINAR

Release & Stability Testing Requirements for Parenteral Drug Products

Published Date: November 7, 2022

Parenteral products are sterile drugs, solutions, emulsions, suspensions. Parenteral products are unique from any other type of pharmaceutical dosage form for the following reasons: All products must be sterile. All products must be free from pyrogenic (endotoxin) contamination.

Release and Stability testing are a vital part of new drug development and is conducted throughout a product’s life cycle. These studies confirm that the quality, safety, and effectiveness of drug products are preserved all through the shelf life as an essential requirement. This presentation will provide a brief overview of the Parenteral Drug Products Release testing as well as the ICH guidelines for Stability testing.

 

20592

Shiri Hecter

M.Sc., ASQ CQA and CSSGB

Shiri Hechter received her master’s degree in organic chemistry from Tel-Aviv University in 2005. During her time at Nelson Labs, Shiri supported the analytical testing of pharmaceutical products.

Complete the form below to access the webinar.